Keywords: Roche, Boniva, Generic approvals, USA, FDA, Osteoporosis, Apotex, Orchid, Mylan
FDA approves first generics of Roche osteo drug Boniva
Article | 20 March 2012
The US Food and Drug Administration yesterday approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly bisphosphonates product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
